Therapeutic Advances in Cardiovascular Disease: 2022, vol: 16, issue:
1)- Thivanka N Witharana, Ranu Baral, Vassilios S Vassiliou. Impact of morphine use in acute cardiogenic pulmonary oedema on mortality outcomes: a systematic review and meta-analysis.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221087587
2)- Stephen Gerfer, Ilija Djordjevic, Kaveh Eghbalzadeh, Navid Mader, Thorsten Wahlers, Elmar Kuhn. Direct oral anticoagulation in atrial fibrillation and heart valve surgery-a meta-analysis and systematic review.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221093963
4)- Gaurav Agarwal, Adrija Hajra, Sandipan Chakraborty, Neelkumar Patel, Suman Biswas, Mark K Adler, Carl J Lavie. Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221105013
5)- Peng Chang, Jiayu Xiao, Zhehao Hu, Alan C Kwan, Zhaoyang Fan. Imaging of left heart intracardiac thrombus: clinical needs, current imaging, and emerging cardiac magnetic resonance techniques.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221107737
6)- James W Malcolmson, Rebecca K Hughes, Abhishek Joshi, Jackie Cooper, Alexander Breitenstein, Matthew Ginks, Steffen E Petersen, Saidi A Mohiddin, Mehul B Dhinoja. Therapeutic benefits of distal ventricular pacing in mid-cavity obstructive hypertrophic cardiomyopathy.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221108816
7)- Stefan T Birkett, Jonathan Sinclair, Sally A Seed, Sean Pymer, Edward Caldow, Lee Ingle, Amy E Harwood, Anselm Egun. Effects of exercise prescribed at different levels of claudication pain on walking performance in patients with intermittent claudication: a protocol for a randomised controlled trial.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221108817
8)- Alexandre Campeau Calfat, Marc Simard, Amina Ouali, Claudia Blais, Caroline Sirois. Polypharmacy among older individuals with heart failure: trends between 2000 and 2017 in the province of Quebec, Canada.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221113946
9)- Sophie C Rier, Suzan Vreemann, Wouter H Nijhof, Vincent J H M van Driel, Ivo A C van der Bilt. Interventional cardiac magnetic resonance imaging: current applications, technology readiness level, and future perspectives.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221119624
10)- Pia I Nottebohm, Daniel Dumitrescu, Stefanie Hamacher, Christopher Hohmann, Navid Madershahian, Stephan Baldus, Hannes Reuter, Marcel Halbach. Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221131203
11)- Andrianto, Mia Puspitasari, Meity Ardiana, Ivana Purnama Dewi, Khubay Alvia Shonafi, Louisa Fadjri Kusuma Wardhani, Ricardo Adrian Nugraha. Association between single nucleotide polymorphism SLCO1B1 gene and simvastatin pleiotropic effects measured through flow-mediated dilation endothelial function parameters.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221132367
12)- Carla Sofia de Almeida Martins, João Abranches Figueiredo Simões de Carvalho, Manuel Vaz da Silva, Luís Martins. The GENICA project - a prospective cohort of heart failure patients with a comprehensive ambulatory approach aiming better outcomes: study protocol.Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221132908
13)- Ravina Barrett, James Hodgkinson. Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England's prescription data during the COVID-19 pandemic (January 2019 to October 2020).Therapeutic advances in cardiovascular disease. 2022, 16: 17539447221137170